Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany sees rise in equipment spending:

This article was originally published in Clinica

Executive Summary

In 2001, German health service expenditure on medical equipment, including bandages, pharmaceuticals and dentures, for the first time outstripped expenditure on medical services, says a report published last week by the federal statistical office. Of the total healthcare expenditure of E225bn ($248bn) in 2001, medical equipment funding amounted to some E60.4bn (26.7%), marginally ahead of the E59.6bn spent on physicians costs (26.4%) and the E51.6bn spent on nursing costs (22.8%). Between 1992 and 2001, expenditure rose by 14.8% after inflation, to 10.9% of GDP, placing it third in the world in terms of healthcare spending. In 2001, per capita expenditure on healthcare was E2,740. At this point some 4.1 million people, or every tenth employee in Germany, worked for the health service, although only 2.7 million were employed as full-time staff.

You may also be interested in...



California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Xaira Launches With $1bn-Plus And End-To-End AI Strategy

ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT061947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel